Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes

被引：4
|
作者：
Motairek, Issam [1 ]
Al-Kindi, Sadeer [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Sch Med, 11100 Euclid Ave, Cleveland, OH 44106 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2023年 / 52卷 / 01期
关键词：
Cardiovascular disease; Type 2 diabetes mellitus; Risk factors; PRIMARY PREVENTION; GLYCEMIC CONTROL; DISEASE; OUTCOMES; THERAPY; ADULTS; INTERVENTIONS; COMPLICATIONS; METAANALYSIS; ASSOCIATION;
D O I：
10.1016/j.ecl.2022.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：135 / 147
页数：13
相关论文
共 50 条
  • [11] Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China
    Yang, Xiaoyun
    Liu, Qian
    Fan, Yuxin
    Ding, Li
    Wang, Ruodan
    Hu, Gang
    Liu, Ming
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [12] Manage cardiovascular risk in patients with type 2 diabetes by using agents with proven cardiovascular benefits
    Writers, Adis Medical
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (05) : 181 - 185
  • [13] Bone markers and cardiovascular risk in type 2 diabetes patients
    Zwakenberg, Sabine R.
    van der Schouw, Yvonne T.
    Schalkwijk, Casper G.
    Spijkerman, Annemieke M. W.
    Beulens, Joline W. J.
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [14] Cardiovascular risk management in type-2 diabetes: Is the patients' cardiovascular risk adequately considered in type-2 specialist diabetes care?
    Brenner, Sophie
    Daikeler, Richard
    Oberaigner, Willi
    Stummer, Harald
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2021, 167 : 6 - 14
  • [15] Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes JACC Guideline Comparison
    Kelsey, Michelle D.
    Nelson, Adam J.
    Green, Jennifer B.
    Granger, Christopher B.
    Peterson, Eric D.
    McGuire, Darren K.
    Pagidipati, Neha J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (18) : 1849 - 1857
  • [16] Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted?
    Ferguson, L. D.
    Sattar, N.
    DIABETES OBESITY & METABOLISM, 2013, 15 (05) : 387 - 391
  • [17] Type 2 diabetes increases the risk of mortality and cardiovascular events in ischemic HFmrEF patients: a retrospective cohort study
    Liu, Zhican
    Hu, Hailong
    Zeng, Jianping
    Jiang, Mingyan
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01)
  • [18] Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study
    Sattar, Naveed
    McMurray, John
    Boren, Jan
    Rawshani, Araz
    Omerovic, Elmir
    Berg, Niklas
    Halminen, Janita
    Skoglund, Kristoffer
    Eliasson, Björn
    Gerstein, Hertzel C.
    McGuire, Darren K.
    Bhatt, Deepak
    Rawshani, Aidin
    CIRCULATION, 2023, 147 (25) : 1872 - 1886
  • [19] Cardiovascular outcomes in type 1 and type 2 diabetes
    Rosengren, Annika
    Dikaiou, Pigi
    DIABETOLOGIA, 2023, 66 (03) : 425 - 437
  • [20] Cardiovascular autonomic neuropathy in patients with type 2 diabetes
    Liu, Yuan
    Liu, Sui-xin
    Zheng, Fan
    Cai, Ying
    Xie, Kang-ling
    Zhang, Wen-liang
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (04) : 615 - 621
12345